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1. Introduction 
The mammalian translocation factor is specifically 
inactivated by diphtheria toxin in the presence of 
NAD+ [ I] . This inactivation has been shown to be 
due to the transfer of the ADP-ribose* moiety of 
NAD+: by diptheria toxin into a covalent linkage with 
the translocation factor [2]. The reaction is prevented 
or reversed by nicotinamide [3] . Using NAD’, radio- 
actively labelled in its adenosine or phosphate moiety, 
it has been possible to label the translocation factor 
radioactively [2,4] and to study different aspects of 
its mode of action [4-lo] . Approximately 1 mole of 
ADP-ribose group is covalently bound to 1 mole of the 
factor [l I]. 
The exact mode of inhibition of mammalian poly- 
peptide-chain elongation, due to ADP-ribosylation of 
the translocation factor remains unknown. The forma- 
tion of a translocation factor-GTP complex does not 
appear to be affected by the ADP-ribosylation of the 
factor [7,8]. Cn the other hand, ADP-ribosylation of 
rat liver aminoacyltransferase II has been shown to re- 
sult in an inhibition of translocation of peptidyl-tRNA 
into a puromycin reactive ribosomal site [ 121 as well as 
in the inhibition of ribosome- and translocation factor- 
dependent GTP hydrolysis [4, 131. Several findings 
have implied that inhibition of polypeptidechain elon- 
gation by diptheria toxin and NAD+ might be due to 
inhibition of the formation of a GTPdependent inter- 
mediate complex between the translocation factor and 
ribosomes [8, 13, 141. In order to clarify this question, 
work was initiated to study the effect that ADP-ribo- 
sylation of the human translocation factor TF II had 
upon the formation of the complex involving TF II, 
GTP and ribosomes [ 151 . Results reported below sug- 
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gest that the ADP-ribose derivative of TF II is capable 
of forming a complex with ribosomes in the presence 
of GTP. 
2. Materials and methods 
Elongation factors and ribosomes were prepared 
from human tonsils as previously described [ 16,171. 
TF I used corresponded to fraction IV [ 16,171. TF II 
used was purified from fraction V [ 171 by phospho- 
cellulose chromatography [ 151. This fraction after the 
phosphocellulose chromatography step will be designated 
as fraction VI. Ribosomes were purified in addition to 
the normal purification procedure [ 161 by including 
a 1 M KC1 washing step. NAD*, labelled with 3H in the 
adenosine moiety, 3 H-NAD’, specific activity 59 1 Ci/ 
mole, was purchased from New England Nuclear 
Chemicals. r4C-GTP, specific activity 36 Ci/mole, and 
3 H-Phe specific activity 1000 Ci/mole and i4C-Phe, 
specific’activity 5 13 Ci/mole, were products of the 
Radiochemical Centre, Amersham. Unlabelled NAD’ 
and nicotinamide were obtained from Merck, poly U, 
GTP, and GDP from Boehringer, Mannheim. Highly 
purified diptheria toxin was a gift from Behring Werke, 
Marburg. 
Binding of 14C-GTP to ribosomes was performed 
as described [ 151. Amounts of TF II, ribosomes, and, 
if present, of diphtheria toxin and NAD’ were as in- 
dicated in the legends. The assays for 3H-ADP-ribosyl- 
ation of TF II, contained in 100 1118 mM MgClz ,60 
mM KCl, 50 mM Tris-HCl pH 7.4,lO mM 2-mercapto- 
* Abbreviations used are: ADP-ribose, adenosine diphosphori- 
hose; poly Phe, polyphenylalanine; TF 1, mammalian amino- 
acyl-tRNA binding factor; TF 11, mammalian translocation 
factor. 95 
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Fig. 1. Reactivation ofribosome-bound ADP-ribosyl-TF II in the presence of diphtheria toxin and nicotinamide, assayed in poly 
Phe synthesis. First incubation (200 ~1, 15 min, 20”): 42 pg TF II fraction VI proteins were incubated in presence or absence of 
17 fig diphtheria toxin and 10 PM NAD’. Conditions otherwise as described under Methods. Second incubation (250 ~1, 5 min, 
37”): 8 Aaso units ribosomes and 1.0 mM GTP were added; ionic conditions of the first incubation were maintained. Thereafter, 
240 pl were layered on 1.8 ml homogenization buffer and ribosomes were centrifuged and resuspended as described under Methods. 
Third incubation (70 ~1, 15 min, 20”): 3 Azeo units ribosomes were incubated in presence of 17 /.tg diphtheria toxin with or with- 
out 20 mM nicotinamide. Ionic conditions as above. Fourth incubation (300 ~1, 60 min, 37”): 150 /.q TF I fraction IV proteins, 
60 pg poly U, 180 fig tRNA (E. co/i), 1.5% charged with 14C-Phe, and 2 mM GTP were added and ionic conditions adjusted to 
those for poly Phe synthesis [ 161. At indicated times incorporated 14C-Phe was determined as described [ 161. Counting efficien- 
cy for 14C was 67%. (o--u--o): toxin and NAD’ absent in first incubation; no nicotinamide in third incubation. (e-e-e): toxin 
and NAD’ absent in first incubation; nicotinamide present in third incubation. (o-o-o): toxin and NAD’ present in first incuba- 
tion; no nicotinanide in third incubation. (e-o-o): toxin and NAD+ present in first incubation; nicotinamide present in third in- 
cubation. (e-e -@): toxin and NAD+ absent in first incubation; GTP omitted in second incubation; nicotinamide absent in third 
incubation. (x-x-x): toxin and NAD’ absent in first incubation;GTP omitted in second incubation; nicotinamide present in 
third incubation. (m-9-e): toxin and NAD’ present in first incubation; GTP omitted in second incubation; nicotinamide present 
in third incubation. (m-o-o): toxin and NAD’ present in first incubation; GTP omitted in second incubation; nicotinamide absent 
in third incubation. (@-@-a): no TF II run in this assay. 
Table 1 
Effect of diphtheria toxin and NAD+ 
upon human poly Phe synthesis. 
System 
Control 
-TF II 
+Diphtheria toxin 
+NAD+ 
+Diphtheria toxin, + NAD+ 
pmoles 3H-Phe incorpo- 
rated per 1 ml, 30 min, 
37” 
166 
3 
167 
174 
11 
Control system contained all the components of the standard 
system of human poly Phe synthesis [ 161 : 10 A260 units/ml 
of ribosomes, 215 rg/ml TF I fraction IV proteins, 26 pg/rnl 
TF II fraction VI proteins, 600 pg/ml tRNA (E. co14 0.9% 
charged with 3H-Phe, and 2 mM GTP were used. If present, 
170 pg/ml diphtheria toxin and 5 crM NAD+ were used. Count- 
ing efficiency for 3H was 20%.. 
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ethanol, 5 PM 3H-NAD*, 17 pg diphtheria toxin and 
TF II fraction VI proteins as indicated in the legends. 
The assays were incubated for 15 min at 20” (the ADP- 
ribosylation reaction reaches a plateau under these 
conditions after ca. 10 min). After the incubation 75 
~1 aliquots were plated on GF/A filters (Whatman) 
and radioactivity precipitable in cold CCl,COOH was 
counted in 2 ml of toluene containing 0.4% 2,5-di- 
phenyloxazole in a Packard (Tricarb) liquid scintilla- 
tion spectrometer. Alternatively, 3H-ADP-ribosylated 
TF II was bound to ribosomes in a second incubation 
(5 min, 37”) after ADP-ribosylation assay. In this case, 
the assays were first chilled on ice and the assay vol- 
umes were, thereafter, increased to 150 d by the ad- 
dition of ribosomes (4-6 AZ60 units) and 1 .O mM GTP 
or 1 .O mM GDP. The ionic milieu was kept constant. 
After the second incubation, the assays were chilled 
again and 140 ~1 were carefully layered on 1.8 ml homo- 
genization buffer [ 161 and centrifuged in an MSE 
Type 10 X 10 rotor for 2.5 hr at 150,000 g. Ribosomal 
pellets were resuspended in 70 fl homogenization buf- 
fer and from each sample 2.5-3.5 AZ60 units of ribo- 
somes were plated on GF/A filters and the ribosome 
bound radioactivity was counted in a Packard liquid 
scintillation spectrometer as above. Poly U-dependent 
poly Phe synthesis was performed as previously des- 
cribed [16] . Amounts of elongation factors used were 
as indicated in the legends. 
3. Results 
In the presence of 5 PM NAD+, diphtheria toxin 
inhibited human poly Phe synthesis more than 90% 
(table 1). The same and even lo-fold higher concen- 
trations of diphtheria toxin and NAD+ failed, however, 
to display a similar inhibitory effect on the TF II-me- 
diated binding of GTP to ribosomes (table 2). 
Moreover, ADP-ribosyl-TF II was apparently cap- 
able of binding to ribosomes in the presence of GTP 
or GDP, as demonstrated by the recovery of radioac- 
tivity in the pellets of ribosomes, incubated with 3H- 
ADP-ribosyl-TF II (table 3). GDP appeared to be at 
least as effective as GTP in the promotion of the bin- 
ding of 3H-ADP-ribosyl-TF II to ribosomes. Some 
binding of the radioactivity to ribosomes could be 
observed also in the absence of a guanosine nucleo- 
tide (32% of the value observed in the presence of 
GTP). 
Alternatively, the GTP-promoted binding of ADP- 
ribosyl-TF II to ribosomes could be demonstrated by 
incubation of ADP-ribosyl-TF II-ribosome complexes, 
purified by centrifugation, in the presence of diphther- 
ia toxin and of nicotinamide (fig. 1): Incubation of 
ADP-ribosyl-TF II-ribosome complexes with diph- 
theria toxin and 20 mM nicotinamide resulted in a 
nearly complete reactivation of the modified and ribo- 
some-bound factor, as assayed in poly Phe synthesis. 
Such ribosomes carrying ADP-ribosyl-TF II displayed, 
however, almost no TF II activity in poly Phe synthe- 
sis, if they were incubated in the absence of nicotin- 
amide. The incubation in the presence of diphtheria 
toxin and nicotinamide had no effect upon the activ- 
ity of the unmodified factor, bound to ribosomes in 
the presence of GTP. 
4. Discussion 
The results show that TF II-mediated binding of 
GTP to ribosomes is not significantly affected by diph- 
theria toxin and NAD’ concentrations otherwise suf- 
ficient to inhibit poly Phe synthesis almost completely. 
The ADP-ribosylation reaction has been previously ob- 
served to result in a slight inhibition of the rat liver 
transferase II (T2) promoted binding of GTP to ribo- 
somes [4]. ADP-ribose derivative of TF II appears not 
only to catalyze the binding of GTP to ribosomes, but 
also to bind itself to ribosomes. The binding of ADP- 
ribosyl-TF II is stimulated several fold in the presence 
of GTP or GDP. These observations imply that ADP- 
ribosyl-TF II is capable of forming a complex together 
with GTP and ribosomes, just as it has been shown to 
be the case with the unmodified form of the factor 
[ 151. Different lines of evidence have previously 
implied that ADP-ribosylated mammalian translocation 
factor is not capable of interacting with ribosomes 
[8, 13, 141. The difference between these previous 
observations and those reported in this communication 
might be explained by the milder centrifugation con- 
ditions of ribosomal complexes used in our case. 
As suggested by previous findings [4, 131, ADP- 
ribosylation of the factor might directly result in the 
inactivation of its ribosome-dependent GTPase activity. 
However, Tiboni and Ciferri have very recently ob- 
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Table 2 
Effect of diphtheria toxin and NAD’ upon TF II-promoted binding 
of “‘C-GTP to ribosomes. 
Additions pmoles 14C-GTP bound 
0.1 ml, 5 min, 37” 
17 fig Diphtheria toxin + 5 PM NAD’ 0.1 
170 fig Diphtheria toxin + 50 PM NAD+ 0.5 
TF II 2.5 
TF II + 17 I.rg diphtheria toxin + 5 PM NAD+ 2.8 
TF 11 + 170 Mg diphtheria toxin + 50 PM NAD’ 2.8 
Ribosomes 1.2 
Ribosomes + 17 I.rg diphtheria toxin + 5 PM NAD+ 1.3 
Ribosomes + 170 fig diphtheria toxin + 50 PM NAD* 1.3 
TF II + ribosomes 14.8 
TF II + ribosomes + 17 Mg diphtheria toxin + 5 I.~M NAD+ 13.3 
TF II + ribosomes + 170 I.rg diphtheria toxin + 50 PM NADf 14.1 
Experimental conditions were described in detail elsewhere [ 151. Assays (100 ~1) contained 8 mM MgC12, 60 mM 
KCl, 50 mM Tris-HCI pH 7.4, 8-10 mM 2-mercaptoethanol, 15 PM 14C-GTP, and the components added as above. 
If present, 18 pg of TF II fraction VI proteins and 2,5 A 260 units ribosomes were used. Bound ’ 4CGTP was deter- 
mined by passing assays through nitrocellulose filters. Blank (~0.4 pmoles) determined by filtering a reaction mix- 
ture without TF II, ribosomes, diphtheria toxin, and NAD+, were subracted from all the values above. Counting ef- 
ficiency for 14C was 67%. 
Table 3 
Binding of 3H-ADP-ribosyl-TF II to ribosomes, as assayed by 
the recovery of the bound radioactivity on pelleted ribosomes. 
System Ribosome-bound radioactivity 
(pmoles/2.7 Az60 units) 
Complete 8.7 
-Diphtheria toxin 0.1 
-TF II 0.1 
-Diphtheria toxin, -TF II 0.1 
-CTP 2.8 
-GTP, + GDP 9.7 
Assay conditions were as described under Methods. Complete 
system contained diphtheria toxin and 135 pgTF II fraction 
VI proteins, equivalent to 123 pmoles 3H-ADP-ribosyl-TF II, 
in the first incubation plus 4.5 A26o units ribosomes and 1.0 
mM GTP (or 1.0 mM GDP) in the second incubation. Minus 
ribosome blank (=0.05 pmoles) was determined by rinsing the 
bottom of the centrifuge tube with 70 ~1 of homogenization 
buffer and counting 50 ~1 out of it on a GF/A filter in a Tri- 
carb. This blank was subtracted from all values. Counting ef- 
ficiency for 3H was 20%. 
” 
served in a cell-free system from P. zopfii that (highly 
purified) translocatidn factor-dependent hydrolysis of 
GTP on 80 S ribosomes is not inhibited by diphtheria 
toxin- and NAD+ -concentrations otherwise almost 
completely inhibitory in poly Phe synthesis [ 181. In 
agreement with this observation, our preliminary ex- 
periments have shown that the product of ADP-ribo- 
syl-TF II-catalyzed binding of GTP to ribosomes is in 
the form of GDP, as analyzed by chromatography on 
poly (ethyleneimine)-cellulose thin layers. These lat- 
ter data suggest hat a function of TF 11, tightly coup- 
led with the translocation step, is primarily affected 
by ADP-ribosylation of the factor. 
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